Data / Form D filings / VOLITIONRX LTD
VOLITIONRX LTD: Form D filings
VOLITIONRX LTD, a biotechnology company in Henderson, NV, filed 15 Form D notices with the SEC between 2011 and 2026. The latest, on January 28, 2026, reports $22.7 million sold of a $22.7 million offering to 1 investor.
SpecStream is the live web data engine for teams and agents. It reads every Form D on SEC EDGAR the day it is filed, and this page is that reading. Ask for your own cut (a state, an industry, a size) and new filings arrive in your sheet, CRM, Slack or agent as they land.
Company details from the filing
- Address
- 1489 West Warm Springs Road, Suite 110, Henderson, NV, 89014
- Phone
- (512) 774-8930
- Industry
- Biotechnology
- Entity type
- Corporation
- Incorporated in
- Delaware
- Revenue range
- Decline to Disclose
- Exemptions claimed
- Rule 506(b)
- SEC identifier (CIK)
- 93314
Form D filings
| Filed | Type | Offering | Sold | Remaining | Investors | First sale | Filing |
|---|---|---|---|---|---|---|---|
| Jan 28, 2026 | Amendment | $22,650,000 | $22,650,000 | 1 | May 20, 2025 | sec.gov | |
| May 30, 2025 | New notice | $16,250,000 | $16,250,000 | 1 | May 20, 2025 | sec.gov | |
| Mar 26, 2024 | New notice | $100,000 | $100,000 | 1 | Mar 12, 2024 | sec.gov | |
| Aug 27, 2018 | New notice | $24,000,000 | $24,000,000 | 1 | Aug 10, 2018 | sec.gov | |
| Nov 21, 2014 | New notice | $721,849 | $721,849 | 21 | Nov 17, 2014 | sec.gov | |
| Oct 14, 2014 | New notice | $229,393 | $229,393 | 10 | Oct 9, 2014 | sec.gov | |
| Oct 14, 2014 | New notice | $750,000 | $750,000 | 23 | Sep 26, 2014 | sec.gov | |
| Sep 25, 2014 | New notice | $1,189,749 | $1,189,749 | 7 | Sep 24, 2014 | sec.gov | |
| Mar 11, 2014 | New notice | $3,000,000 | $3,000,000 | 24 | Feb 26, 2014 | sec.gov | |
| Dec 3, 2013 | New notice | $1,000,000 | $934,923 | $65,077 | 7 | Nov 25, 2013 | sec.gov |
| Jun 14, 2013 | New notice | $1,500,000 | $595,000 | $905,000 | 27 | Jun 10, 2013 | sec.gov |
| May 8, 2013 | New notice | $500,000 | $416,000 | $84,000 | 8 | May 1, 2013 | sec.gov |
| Mar 27, 2013 | New notice | $500,000 | $489,583 | $10,417 | 19 | Mar 25, 2013 | sec.gov |
| Jul 26, 2012 | New notice | $3,000,000 | $1,204,152 | $1,795,848 | 33 | Apr 24, 2012 | sec.gov |
| Oct 28, 2011 | New notice | $1,727,163 | $1,727,163 | 38 | Oct 6, 2011 | sec.gov |
Executive officers and directors named in the filing
| Name | Role | Note in the filing |
|---|---|---|
| Cameron Reynolds | Executive Officer, Director | |
| Terig Hughes | Executive Officer | |
| Rodney Rootsaert | Executive Officer | |
| Louise Batchelor | Executive Officer | |
| Salvatore Thomas Butera | Executive Officer | |
| Gael Forterre | Executive Officer | |
| Jasmine Kway | Executive Officer | |
| Jacob Micallef | Executive Officer | |
| Gaetan Michel | Executive Officer | |
| Nicholas Plummer | Executive Officer | |
| Alan Colman | Director | |
| Mickie Henshall | Director | |
| Guy Archibald Innes | Director | |
| Kim Nguyen | Director | |
| Phillip Barnes | Director | |
| Timothy I Still | Director | |
| Ethel Rubin | Director |
Other biotechnology companies in Nevada that filed recently
- Palimpsest Bio Corp. $172,000 · Oct 30, 2026
- Conexeu Sciences Inc. $1.5 million · Oct 21, 2026
Every Form D from the week of Jan 26, 2026 · All recent filings in Nevada · All recent Biotechnology filings
Read from SEC EDGAR. Amount sold is what VOLITIONRX LTD reported on the day it filed; on an offering that is still open, a later amendment can raise it. Free to reuse with credit to SpecStream under CC BY 4.0.